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Lack of translocation of protein kinase C from the cytosol to the
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The ability of Ca2+-mobilizing hormones to promote changes in the subcellular distribution of protein kinase C (PKC)
was studied in isolated hepatocytes. In recently isolated cells the distribution of PKC between the soluble and particulate
fractions was 47 and 53 % respectively. Exposure of the hepatocytes to 100 nM-vasopressin produced an increased
phosphoinositide turnover, as reflected by the changes in the concentrations of inositol trisphosphate and Ca2+, and in
glycogen phosphorylase a activity. However, the distribution of both PKC activity and [3H]phorbol dibutyrate binding
between the cytosol and the membranes remained unchanged under these conditions. To determine the threshold values
of the concentrations of Ca2+ and diacylglycerol required to produce a redistribution ofPKC, the hepatocytes were treated
with the Ca2+ ionophore ionomycin, and with permeant diacylglycerol derivatives. Hepatocytes incubated in the presence
of 100 nM-vasopressin required concentrations of Ca2+ 2.5 times those produced physiologically by the hormone to
produce translocation of PKC from the cytosol to the membranes. These studies suggest that, at least in hepatocytes,
activation of PKC in response to Ca2+-mobilizing hormones involves only the pre-existent membrane-bound enzyme
without affecting the soluble enzyme.
INTRODUCTION
The occupancy of [arginine]vasopressin (VP) receptors of the
hepatocyte plasma membrane elicits the generation of intra-
cellular signals through the participation of a guanine-nucleotide-
binding protein (G-protein) that acts as an amplifying and
regulatory component of the extracellular signal-transduction
system [1-3]. This G-protein, in turn, activates a phosphatidyl-
inositol-specific phospholipase C which leads to a rapid increase
in the concentration of diacylglycerol (DAG) and inositol
phosphates [4-7], the latter being responsible for the transient
rise in the free cytosolic Ca2+ concentration [8,9].
One of the rapid responses to the increased phosphoinositide
turnover is the activation of protein kinase C (PKC) by the
synergistic action of DAG and Ca2+ [10,11]. This kinase
participates in a wide type of biological responses, among them
being the control of several steps of the intermediary metabolism
and phosphorylation of membrane proteins [12-15].
PKC is distributed between the cytosol and particulate
fractions of the cells. Only the membrane-bound enzyme seems
to participate in the mediation of biological responses elicited
through phosphoinositide turnover [16,17]. Stimuli-dependent
translocation of the enzyme to the membranes should therefore
be expected for hormones using this pathway. However, in
metabolically active tissues such as brain or liver, a high
percentage of the enzyme is continuously present in particulate
fractions, whereas in quiescent and resting cells most of the
activity is found in the cytosol [12,18,19]. The physiological role
of the membrane-bound enzyme in the absence of added
extracellular stimuli is not clear. In the brain, it has been
proposed that this particulate enzyme may participate in the
mechanism of memory [20].
In this context we investigated the subcellular distribution of
PKC in hepatocytes exposed to VP. The aim of the present work
was to determine whether the rises in the concentrations ofDAG
and Ca2+ elicited by VP influence the subcellular compart-
mentation of the enzyme. The measurements of the changes in
the intracellular concentrations of Ca2l, InsP3 and the activity of
glycogen phosphorylase, an enzyme very sensitive to changes in
Ca2+ concentration, may serve as controls for the function of the
VP signalling pathway in the hepatocytes. In this report we show
that exposure of hepatocytes to saturating concentrations of VP
did not produce changes in the distribution of PKC. In addition,
we provide quantitative information on the amounts of the
second messengers (mainly Ca2+) required to mobilize PKC from
the cytosol to the membranes.
MATERIALS AND METHODS
Chemicals
[y-32PJATP (3000 Ci/mol) and [3H]phorbol 12,13-dibutyrate
(PDBu, 20 Ci/mmol) were from New England Nuclear (Boston,
MA, U.S.A.). InsP3 assay system was from Amersham Inter-
national (Amersham, Bucks., U.K.). Fura-2 probes were from
Molecular Probes (Eugene, OR, U.S.A.). Ionomycin was from
Calbiochem, VP, histone Hl, phosphatidylserine, dioctanoyl-
glycerol, l-oleoyl-2-acetyl-rac-glycerol (OAG) and phorbols were
from Sigma (St. Louis, MO, U.S.A.). Nonidet P-40 was from
USB (Cleveland, OH, U.S.A.). Other chemicals were from Merck
or Boehringer.
Isolation and incubation of hepatocytes
Hepatocytes were isolated from male Wistar rat livers by
digestion with collagenase [21]. The hepatocytes were filtered
through a 100 um nylon mesh, and washed three times with
Krebs-Ringer bicarbonate buffer saturated with 02/C02 (19: 1)
by centrifugation at 50 g for 2 min in a refrigerated centrifuge
(Minifuge T, Haereus). This procedure gave a cell preparation
virtually free of membrane fragments, as assessed by microscopic
observation. The hepatocyte suspension contained 100-150 mg
of cells/ml. Only preparations with cell viability higher than
90 %, determined by Trypan Blue exclusion, were used.
The incubations were stopped by centrifugation for 10 s in an
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Eppendorf centrifuge. Samples for the measurement of enzymic
activities were immediately frozen in liquid N2 (0.3 and 1.5 ml
samples for glycogen phosphorylase and PKC respectively). For
determination of InsP3, the cells were treated with 1 vol of ice-
cold 0.2 M-HC1O4 and stored at 4 'C.
Measurement of metabolites
The absolute mass of InsP3 was measured by following the
recommendations of the supplier. Appropriate internal standards
were used to determine the accuracy of the assay [22,23].
To measure the intracellular Ca2l concentration, the
hepatocytes were transferred at 20 mg of cells/ml to a modified
Krebs-Ringer buffer in which the bicarbonate was replaced by
20 mM-Hepes, pH 7.4, to decrease the noise caused by the
appearance of CO2 bubbles, and filtered through a 100 #rsm nylon
mesh. The cells were loaded at 37 'C with fura-2 AM for 10 min
(final concn. 5/ M) with continuous shaking (40 cycles/min).
After this incubation, 3 ml samples of the hepatocyte suspension
were washed twice by centrifugation at 100 g for 2 min,
resuspended in warm medium and placed in a spectrofluorimetric
cuvette provided with continuous magnetic stirring. The
fluorescence was recorded in a Perkin-Elmer L50 spectro-
fluorimeter. The maximal fluorescence was determined at the end
of the assay by adding 10,ul of 10% (w/v) SDS. The minimal
fluorescence was obtained by adding 30 dzl of 0.2 M-EGTA
(pH 9.0) [24].
Measurement of enzyme activities
Glycogen phosphorylase a activity was measured essentially as
described by Stalmans & Hers [25], by monitoring the phosphate
release from glucose 1-phosphate (50 mM) in the presence of
100 mM-NaF, 1 % glycogen and 0.5 mM-caffeine at pH 6.1.
To measure PKC activity, the hepatocyte pellets (200-300 mg
of cells) were homogenized in 2 ml of ice-cold 0.25 M-sucrose
containing 10 mM-fl-mercaptoethanol, 1 mM-EGTA, 1 mm-
EDTA, 1 mM-phenylmethanesulphonyl fluoride, 10,ug of leu-
peptin/ml and 20 mM-Hepes, pH 7.4 (buffer A). The homogenate
was centrifuged at 105000 g for 30 min, yielding a soluble and a
particulate fraction (pellet). To extract the membrane-bound
enzyme, the pellet was resuspended in 2 ml of buffer A
supplemented with 0.1 % Nonidet P-40, followed by
centrifugation (105000 g for 20 min). The soluble and membrane-
bound extracted enzymes were partially purified by
chromatography on DEAE-cellulose (DE52) after elution with
150 mM-NaC1 to remove the inhibitors of the enzyme present in
the homogenate [26]. The activity of PKC was monitored by the
phosphorylation of histone HI in the absence and presence of
Ca2 , phosphatidylserine and DAG as previously described
[27,28]. One unit ofPKC was defined as incorporating I nmol of
phosphate into histone H 1/min.
13HIPDBu-binding assay
Binding of [3H]PDBu was measured in the soluble and
particulate fractions of 1:4 (w/v) homogenates of hepatocytes
[29,30]. For the cytosolic activity, the supernatants were desalted
by gel filtration on Sephadex G-25 (medium grade) equilib-
rated with 100 mM-KCI/5 mM-MgCl2/0.05 mM-EGTA/10 mm-
,l-mercaptoethanol/leupeptin (10 ,ug/ml)/20 mM-Hepes, pH 7.5.
The particulate fractions were resuspended in the same medium.
The PDBu binding was performed by incubating for 10 min at
30 IC, in 150 ,ul, a mixture containing 100 1 of sample, 100 ,aM-
Ca2+ and [3H]PDBu in the absence or in the presence of 2 ,/M
non-radioactive PDBu. The assay for the cytosol contained
100 ,ug of sonicated phosphatidylserine/ml. Equilibrium binding
was reached after 1-2 min of incubation. To calculate the specific
binding, the binding in the presence of an excess of unlabelled
PDBu (2/SM) was subtracted from the corresponding assay [27].
Translocation of PKC in vitro
This was analysed by incubating plasma membranes [31] with
soluble PKC purified by DE52 chromatography. Samples of
incubation mixtures (200,1) were collected at various times,
centrifuged at 105000 g for 30 min, and the activity of PKC was
measured in the soluble and membrane-bound fractions after
extraction with buffer A in the presence of 0.1 % Nonidet P-40.
All reagents used for these experiments were prepared in Chelex-
treated water (Na+ form).
Protein was determined as described by Bradford [32], with
bovine serum albumin as standard.
RESULTS
To analyse the effect of VP on the subcellular distribution of
PKC, the hepatocytes were incubated with the agonist, and
samples were periodically collected to determine the activities of
glycogen phosphorylase and of PKC in the soluble and par-
ticulate fractions, and the content of InsP3. Fig. 1 shows the
evolution of these parameters in hepatocytes incubated with
100 nM-VP. The stimulation of glycogen phosphorylase activity
and the rise in the concentration of InsP3 agree with previously
reported results [22,23,33,34]. Despite the rise in the
phosphoinositide turnover elicited by VP, the distribution of
PKC between soluble and particulate fractions remained virtually
unchanged, at least during the 12 min period of observation.
c
._
- 100
0
E
8E
E
0 O
r-
L._
co
c cnE78
E
C
c
.5
>
._
OE
CJ
c
la
4
2
0 2 4 6 8 10 12
Time (min)
Fig. 1. Time-dependent changes in the activity of glycogen phosphorylase a
(a), InsP3 concentration (b) and PKC distribution (c) in isolated
hepatocytes incubated with 100 nM-VP
At the indicated times, samples of the cell incubations were collected
to measure these parameters. The distribution of PKC between the
soluble (A-) and particulate (A) fractions was measured after partial
purification of the enzyme by DE52 chromatography. Results are
means+S.E.M. for three different determinations, except for the
measurement of InsP3 (n = 2).
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Fig. 2. Dose-dependent effect ofVP on the intraceUlular Ca2l concentration
and glycogen phosphorylase a activity (a) and PKC distribution (b)
in isolated hepatocytes
The cells were incubated for 2 min with the hormone, and samples
were collected for the measurement of glycogen phosphorylase (0).
the intracellular Ca2l concentration (0) (a) and the soluble (AL) and
particulate (A) activity of PKC (b). The changes in Ca2l were
monitored by the fluorescence of fura-2-loaded hepatocytes. The
maximal increase in the concentration of Ca2+ is shown. Results are
means + S.E.M. of three independent experiments.
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Fig. 3. I3HIPDBu-binding distribution between the soluble and particulate
fractions from control or 100 nM-VP-treated hepatocytes
Cells (0.9-1.0 g) were incubated for 2 min in the absence (0) or
presence (0) of the hormone and immediately homogenized and
centrifuged (1050OOg for 30min). The [3H]PDBu binding was
measured in the cytosol (a) and in the particulate fraction (b).
Results are means + S.E.M. of three assays.
Moreover, the PKC activity present in the particulate fraction
was minimally, but significantly, decreased after the incubation
with VP (36% of the total activity in the particulate fraction
after 12 min of incubation; P < 0.001).
To determine whether larger concentrations ofVP (up to 1 uM)
may influence the subcellular distribution of PKC, the
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Fig. 4. Effect of Ca2" on the activity of glycogen phosphorylase a and on
PKC distribution in hepatocytes
Cells were incubated in the absence (A, 0, El) or in the presence
(A, 0, *) of 2 ,uM-ionomycin. Samples were collected to measure
glycogen phosphorylase activity (a) and PKC distribution between
the soluble (0, 0) and particulate (O, *) fractions (b). Results are
means of two independent determinations.
hepatocytes were incubated for 2 min in the presence ofincreasing
concentrations of hormone. The cells were analysed for the
activity of glycogen phosphorylase, the changes in the intra-
cellular free Ca2+ concentration, and PKC activity distribution.
As Fig. 2 shows, even at saturating concentrations of VP, no
changes in PKC distribution were observed. However, glycogen
phosphorylase was maximally stimulated; the intracellular con-
centration of Ca2+ reached values of about 0.8,UM at 100 nM
concentrations of the hormone. One possible explanation for this
lack of redistribution of PKC by VP is the presence of non-
accessible pools of PKC in the cytosol. For this reason, to
maintain a positive control over the distribution of PKC among
the soluble and particulate fractions, 100 ng of PDBu/ml was
added to an incubation in the presence of 100 nM-VP, resulting
in the complete disappearance of PKC from the cytosol, after its
translocation towards the membranes (results not shown). This
result suggests that the cytosolic enzyme was freely accessible to
the phorbol and, therefore, to the metabolites that transduce the
VP-binding signal.
The distribution ofPKC shown in Figs. I and 2 was determined
by monitoring its histone kinase activity. To obtain an additional
criterion for the distribution of PKC after VP incubation, the
amount of enzyme present in each compartment was measured
by monitoring the [3H]PDBu binding to the soluble and par-
ticulate fractions. Fig. 3 shows the distribution of binding sites in
hepatocytes incubated in the absence or presence of 100 nM-VP
for 2 min. The amounts of binding sites in the particulate and
soluble fractions were 2.1-2.4 pmol/mg of tissue protein for
control and VP-treated cells. The same distribution was also
observed in cells incubated -for 10 min with the hormone (results
not shown).
As a further analysis of the factors relevant to the distribution
ofPKC in the hepatocytes, the concentrations of Ca2' and DAG,
the two signals that mediate the action of the hormone, were
modulated by the use of the Ca2+ ionophore ionomycin, which
allows the determination of the hepatocyte Ca2+ entry by fura-2
analysis, and the permeant DAG derivatives dioctanoylglycerol
and OAG. Fig. 4 shows the activities of glycogen phosphorylase
and PKC in hepatocytes incubated for I min with 2#M-
ionomycin and different extracellular Ca2+ concentrations. In the
absence of ionophore, the activity of glycogen phosphorylase
and the PKC distribution remained unchanged regardless of the
extracellular concentration of Ca2+ (up .to .5 mM; result not
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Table 1. lonomnycin-induced redistribution of PKC in isolated rat
hepatocytes
Cells were incubated for 10 min with Krebs-Ringer bicarbonate
containing 1.5 mm-CaCl and 10 ,sg of leupeptin/mi, and exposed to
2 /Sm-ionomycin. Samples were collected to analyse PKC distribution
between the soluble and particulate fractions. In a parallel'incubation
-the hepatocytes were loaded with fura-2 (5 /sm) a'nd analysed for the
changes in Ca2' after exposure to ionomycin. Results are meaIns + S.E.M.
of four different experiments for-PKC distribution, or means of two
experiments for Ca2+ concentration. Values that are significantly
different from the control are indicated by * P < 0.05 or ** P < 0.001.
PKC activity
(units/mg of protein)
Incubation time [Ca2+
(min) Soluble Particulate (FsM)
0 3.5+0.2 3.1+0.2 0.17
0.5. 3.4+0.3 3.3+0.1 0.92
1.0 2.9+0.2* 3.6+0.3* 1.93
2.0 2.1l+0.3** 4.3+0.3** 3.73
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Fig. 6. Effect of Cal' and DAG on the distribution ofPKC in a reconstituted
system containing hepatic plasma membranes and purified soluble
PKC
Plasma membranes were purified by centrifugation on sucrose
gradients, and incubated for 5 min with the soluble enzyme and
increasing concentrations of Cal' and in the absence (0) or presence
(A) of 40 #g of OAG/ml. (a) PKC activity in the cytosol; (b) PKC
activity extracted from the membranes. The incubation was stopped
by centrifugation at 41000 g for 15 min Proteolysis was prevented
by adding 10 ,sg of leupeptin/ml to the assay. The reagents were
treated wittr Chelex resin to remove any, pontaminant Call. Results
are mean~ of duplicate translocation assays in vitro.
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Fig. 5. Effect of OAG on the subceliular distribution of PKC in isolated
hepatocytes
Cells were exposed to 250 ,ug ofOAG/ml and samples were collected
to analyse the content of PKC in the particulate fractions. 0,
Control cells; 0, OAG-exposed cells. Results are means + S.E.M. Of
three different experiments.
shown). However, in the presence of the ionophore, glycogen
phosphorylase was activated by the entry of extracellular Ca21 in
a concentration-dependent form, suggesting a linear entry of
Ca . When the distribution of PKC was analysed in the same
experiment., a lag in the response to the translocation towards the
membranes was observed at concentrations of Ca2+ up to 2 mmr.
The changes in PKC distribution required at least 5 mm-Ca2 ,
whereas for the activation of glycogen phosphorylase the
threshold was mm. When the hepatocytes were incubated in a
medium containing 10 mm-Ca2 the ionophore-mdae
of Ca2+ translocated about 70 % of the total enzyme. These
results are in agreement with previous data concerning the role
of Ca2+ in the distribution of PKC [35].
To establish the threshold value of Ca2+ required to promote
PCredistribution, hepatocytes were exposed to ionomycin
-(2 #m) and samples were collected at several times to -analyse the
PKC content in the cytosol and in the particulate fractions. In
parallel, hepatocytes were loaded with fura-2 and analysed for
Ca2+ Mobilization under similar conditions to those used for
PKC analysis. As Table~ shows, only concentrations of Ca2+
higher than 2/gm promoted significant changes in PKC dis-
tribution. These results are in agreement with the absence of
PKC changes after VP exposure of the hepatocytes, since the
Ca2+ increase elicited by this hormone is below l/Sm.
To determnine whether DAG may affect the translocation of
PKC from the cytosol to the membranes, hepatocytes were
incubated with the permeant DAGs OAG and dioctanoylglycerol.
As Fig. 5 shows, high concentrations ofOAG (250 ,zm) produced
a small (20-30%) but significant time-dependent translocation
of the enzyme to the membranes. The process was very rapid (less
than min) and remained at least for 5 min. Lower
concentrations of OAG (20-100 ,sm) failed to redistribute PKC
during the observation time. In addition to OAG, dioctanoyl-
glycerol produced roughly similar results. When a parallel
experiment was conducted, but with hepatocytes incubated for
2 min with 250 ,zm-OAG and 100 nm-VP, to provide a
physiologically high Ca2+ concentration, the PKC translocation
remained unchanged, suggesting a lack of synergism between
both activators.
The ability of Ca2+ and DAG to redistribute hepatic PKC was
also analysed in a cell-free system by using purified plasma
membranes and hepatic PKC partially purified by DE52
chromatography. As Fig. 6 shows, Ca2+ at concentrations higher
than 2 4um effectively promoted the translocation of the enzyme
towards the membranes. The presence of leupeptin in the
translocation assay was critical to obtain a quantitative recovery
of PKC in the plasma membrane fractions. When OAG
(10 ,sg/ml) was also present in the translocation assay, the PKC
distribution was only slightly affected at low concentrations of
Ca2+ (below 5/tm), which also suggests a lack of co-operativity
between these PKC activators in the control of the translocation
of this kinase in liver.
DISCUSSION
Translocation of PKC from the cytosol to particulate cellular
compartments is a process elicited by several PKC ligands,
among which are-Ca2+, DAG, long-chain unsaturated fatty acids
a-nd lipid moieties from lipopolysaccharides, [35-37]. The extent
of the translocation may vary, depending on the cell type and on
the-pathway, used-to, produce-these PKC, figarids.
In the present work the relationship between the changes in the
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concentrations of DAG or free cytosolic Ca2+and their effect on
the subcellular distribution of PKC were investigated in isolated
hepatocytes. VP is a good agonist to produce phosphoinositide-
derived metabolites, because hepatocytes contain a large number
of VP receptors, higher than those for angiotensin II or related
Ca2+-mobilizing hormones [38,39]. Furthermore, at saturating
concentrations VP preferentially mobilizes the Ca2+ coming from
intracellular stores. Finally, the rise in the concentration ofDAG
elicited by VP seems to be quite stable, as determined by different
groups, and it may be estimated to be approx. 2-3 nmol of fatty
acid/mg dry wt. of hepatocytes [38-40]. This rise occurs despite
the presence of an important DAG kinase activity, which is also
stimulated by VP, that may remove part of the DAG formed
[41].
In agreement with these changes elicited by VP, a VP-
dependent translocation of PKC should be found from the
cytosol towards the particulate compartment as a consequence
of the VP-induced enhancement of Ca2+ and DAG. Surprisingly,
VP failed to redistribute PKC in hepatocytes. This failure may
not be attributed to a lack of response to the hormone, since
large increases in Ca2+ and InsP3 and in the activity of glycogen
phosphorylase a had been measured as controls in the same
experiment. According to our results and to those from other
groups, phosphorylase activation is completed within 30 s [33,42].
Thus a nearly similar time course for the activation of PKC
should be expected, since Ca2l and DAG were produqd at
similar rates and the concentration of the agonist was saturating.
It has been suggested that only the membrane-bound enzyme
is active after formation of a complex with DAG, Ca2+ and
membrane phospholipids [43-45]. For example, this is the case in
ras-transformed cells that contain high constitutive levels of
DAG and where PKC is mostly found in the membrane-bound
compartment. Moreover, the total content in PKC in ras-
transformed rat fibroblasts is markedly lower than that found for
control cells, suggesting that continuous activation of PKC may
produce a partial degradation of the enzyme [46-48]. The same
holds true for the interleukin-2-induced association ofPKC with
the plasma membrane in murine T lymphocytes [49].
In liver, different lines of evidence have shown that PKC is
involved in the mechanism of action of VP [50,51], and therefore,
according to our results, it may be suggested that only the pre-
existing enzyme bound to the membranes is activated by the
second messengers elicited after hormone binding. The ancillary
conclusion to this result is that the soluble enzyme is not
recruited to mediate the response to VP stimulation of the
hepatocytes. Thus the conclusion from these results is that the
concentrations of messengers required to translocate PKC from
the cytosol to the membranes are higher than those produced by
the hormone. Other alternatives, such as the saturation of the
membrane PKC-binding capacity, or the presence of a soluble
PKC pool not accessible to these messengers generated by the
hormone, seem unlikely, since PDBu is able to translocate
soluble PKC to the membrane completely, as occurred when
increasing concentrations of Ca2+ and DAG were used.
A clear result obtained from these experiments is the
quantification of the concentrations of Ca2+ and DAG, the
physiological metabolites that translocate PKC, required to
mobilize the enzyme to the membranes. By using a Ca2+
ionophore and a permeant derivative of DAG, it was possible to
establish the minimal concentration of these molecules required
to promote changes in PKC distribution. For OAG, we have
shown that concentrations below 200 uM were unable to promote
the translocation of PKC. This concentration of OAG is much
higher than those required to produce activation of PKC in vivo
[52]. For Ca2", the threshold concentration for the mobilization
of PKC is about 2 4uM-Ca2+.
The messengers produced after VP-receptor occupancy only
activate the membrane-bound enzyme, since DAG is located
only in that compartment. Thus the question emerging from
these results is whether to assess a biological role with respect to
the distribution of PKC in hepatocytes. Our hypothesis is that
the soluble enzyme constitutes a reservoir of functional enzyme
that may be mobilized to the membranes to replace the particulate
PKC that is proteolysed as a result of either long-sustained high
concentrations of DAG or an eventual enhancement of the Ca2+
uptake similar to that elicited by several xenobiotics. In agreement
with this suggestion is the observation that the down-regulation
of PKC is mainly due to the proteolysis of the enzyme [53].
We are indebted to E. Lundin for his help in the preparation of the
manuscript. This work was supported by grant PM88-0025 from
Comis6n Interministerial de Ciencia y Technologia, Spain.
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